Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Research and Innovation Action · Running

iN-KEY iNK Cell–Driven Strategies for Enhanced Multiple Myeloma ImmunotherapY

Coordinator
Banc De Sang I Teixits, Spain
Runs
1 October 2026 to 30 September 2031
Status
Running
EU funding
€10.0m
Total cost
€10.0m
Partners
13 organisations in 5 countries
Type
Research and Innovation Action
Grant agreement
101287295

What the project is doing

In the project's own words, from its summary on CORDIS.

Despite the transformative potential of CAR-T cell therapies, their widespread adoption is hindered by significant barriers, including prohibitive costs, severe toxicities, logistical challenges in manufacturing, and limited efficacy. The iN-KEY consortium aims to overcome these challenges by developing and clinically validating a next-generation, ""off-the-shelf"" immunotherapy platform for the treatment of Multiple Myeloma (MM).

At the heart of this project is a disruptive platform based on engineered induced Pluripotent Stem Cells (iPSCs). This platform integrates several key innovations: 1) Highly immunocompatible, haplo-matched iPSC lines for broad allogeneic use

Topics

Who is involved

OrganisationCityCountryRole
Banc De Sang I TeixitsBarcelonaSpainCoordinator
Myeloma Patients Europe AisblBruxellesBelgiumParticipant
Bundesinstitut Fur Impfstoffe Und Biomedizinische ArzneimittelLangenGermanyParticipant
Catalent Dusseldorf GmbHLangenfeldGermanyParticipant
Miltenyi Biotec BV & Co KgBergisch GladbachGermanyParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Avanther Therapeutics SLMadridSpainParticipant
Fundacio Institut D'investigacio Biomedica De BellvitgeL'Hospitalet De LlobregatSpainThird party
Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncologicas Carlos IiiMadridSpainParticipant
Institut Catala D'oncologiaHospitalet de LlobregatSpainParticipant
Stab Therapeutics SLMadridSpainParticipant
Commissariat a L Energie Atomique Et Aux Energies AlternativesParisFranceParticipant
Eatris EricAmsterdamNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI